1.
Magy Onkol
; 56(2): 114-32, 2012 May.
Article
in Hungarian
| MEDLINE
| ID: mdl-22724157
Subject(s)
Lung Neoplasms/diagnosis , Lung Neoplasms/therapy , Anaplastic Lymphoma Kinase , Antineoplastic Agents/therapeutic use , Chemoradiotherapy, Adjuvant , ErbB Receptors/genetics , Humans , Lung Neoplasms/genetics , Lung Neoplasms/pathology , Lung Neoplasms/prevention & control , Molecular Targeted Therapy/methods , Mutation , Neoadjuvant Therapy/methods , Neoplasm Staging , Primary Prevention/methods , Prognosis , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins p21(ras) , Receptor Protein-Tyrosine Kinases/genetics , Risk Assessment , Risk Factors , Secondary Prevention/methods , ras Proteins/genetics
2.
Magy Onkol
; 55(2): 117-27, 2011 Jun.
Article
in Hungarian
| MEDLINE
| ID: mdl-21780330